Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

DTIL

Precision BioSciences (DTIL)

Precision BioSciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:DTIL
DateTimeSourceHeadlineSymbolCompany
09/20/20246:01AMBusiness WirePrecision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:DTILPrecision BioSciences Inc
09/12/20247:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DTILPrecision BioSciences Inc
09/12/20246:15AMBusiness WirePrecision BioSciences Strengthens Senior Leadership Team Ahead of Anticipated PBGENE-HBV Clinical ExecutionNASDAQ:DTILPrecision BioSciences Inc
09/04/20246:01AMBusiness WirePrecision BioSciences to Participate in Upcoming H.C. Wainwright 26th Annual Global Healthcare ConferenceNASDAQ:DTILPrecision BioSciences Inc
09/03/20247:03AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DTILPrecision BioSciences Inc
09/03/20246:01AMBusiness WirePrecision BioSciences Receives $13 Million in Proceeds from Imugene Convertible Note Maturity as Part of the August 2023 Azer-cel DealNASDAQ:DTILPrecision BioSciences Inc
08/23/20246:30AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DTILPrecision BioSciences Inc
08/23/20246:30AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DTILPrecision BioSciences Inc
08/23/20246:30AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DTILPrecision BioSciences Inc
08/23/20246:30AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DTILPrecision BioSciences Inc
08/09/20246:01AMBusiness WirePrecision BioSciences Announces Investigational New Drug Clearance by Partner TG Therapeutics for Investigation of Azer-Cel for Multiple SclerosisNASDAQ:DTILPrecision BioSciences Inc
08/01/20246:30AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:DTILPrecision BioSciences Inc
08/01/20246:30AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DTILPrecision BioSciences Inc
08/01/20246:15AMBusiness WirePrecision BioSciences Reports Second Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:DTILPrecision BioSciences Inc
07/31/20246:01AMBusiness WirePrecision BioSciences to Participate in Upcoming August Investor ConferencesNASDAQ:DTILPrecision BioSciences Inc
07/29/20243:15PMBusiness WirePrecision BioSciences to Report Second Quarter Results on August 1, 2024NASDAQ:DTILPrecision BioSciences Inc
07/08/20246:01AMBusiness WirePrecision BioSciences to Present at the Upcoming JonesTrading Healthcare Seaside SummitNASDAQ:DTILPrecision BioSciences Inc
07/01/20246:01AMBusiness WirePrecision BioSciences Announces its Addition to the Russell Microcap® IndexNASDAQ:DTILPrecision BioSciences Inc
06/27/20246:01AMBusiness WirePrecision BioSciences Announces Presentation at UMDF Mitochondrial Medicine 2024 Supporting Advancement of PBGENE-PMM Program Towards IND and/or CTA in 2025NASDAQ:DTILPrecision BioSciences Inc
06/20/20246:00AMBusiness WirePrecision BioSciences Expands Hepatitis Scientific Advisory Board with Addition of World-Class Clinical Investigators Mark Sulkowski, M.D. and Jordan Feld, M.D., MPH, as PBGENE-HBV Program Nears Clinical ReadinessNASDAQ:DTILPrecision BioSciences Inc
06/11/20244:13PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DTILPrecision BioSciences Inc
06/11/20244:13PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DTILPrecision BioSciences Inc
06/11/20244:12PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DTILPrecision BioSciences Inc
06/10/20242:15PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:DTILPrecision BioSciences Inc
06/10/20242:12PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:DTILPrecision BioSciences Inc
06/10/20247:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DTILPrecision BioSciences Inc
06/06/20243:37PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DTILPrecision BioSciences Inc
06/06/20243:37PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DTILPrecision BioSciences Inc
06/06/20243:37PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DTILPrecision BioSciences Inc
06/06/20243:37PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DTILPrecision BioSciences Inc
 Showing the most relevant articles for your search:NASDAQ:DTIL